000			01571nam a2200361 a 4500
001			EBC3378890
003			MiAaPQ
005			20240121044037.0
006			m o d |
007			cr cn|||||||||
008			121114s2011 dcua sb 000 0 eng d
020			_a9780309219297 (electronic bk.)
035			_a(MiAaPQ)EBC3378890
035			_a(Au-PeEL)EBL3378890
035			_a(CaPaEBR)ebr10506513
035			_a(CaONFJC)MIL331196
035			_a(OCoLC)923284553
040			_aMiAaPQ _cMiAaPQ _dMiAaPQ
050		4	_aR853.C55 _bP83 2011
245	0	0	_aPublic engagement and clinical trials _h[electronic resource] : _bnew models and disruptive technologies : workshop summary / _cVictoria Weisfeld, Rebecca A. English, and Anne B. Clairborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation Board on Health Sciences Policy, Institute of Medicine of the National Academies.
260			_aWashington, D.C. : _bNational Academies Press, _c2011.
300			_axvi, 99 p. : _bcol. ill.
504			_aIncludes bibliographical references.
533			_aElectronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
650		0	_aClinical trials.
655		4	_aElectronic books.
700	1		_aWeisfeld, Victoria.
700	1		_aEnglish, Rebecca A.
700	1		_aClaiborne, Anne B.
710	2		_aInstitute of Medicine (U.S.)
710	2		_aProQuest (Firm)
856	4	0	_uhttps://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=3378890 _zClick to View
999			_c206237 _d206238